Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A century of BCG: Impact on tuberculosis control and beyond
Asma Ahmed, Srabanti Rakshit, Vasista Adiga, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 98-121
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

100 years of Mycobacterium bovis bacille Calmette-Guérin
Christoph Lange, Peter Aaby, Marcel A. Behr, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. e2-e12
Open Access | Times Cited: 146
A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin
Qiyao Chai, Shanshan Yu, Yanzhao Zhong, et al.
Science (2022) Vol. 378, Iss. 6616
Closed Access | Times Cited: 102
Mycobacterium tuberculosis Transmission in High-Incidence Settings—New Paradigms and Insights
Mikaela Coleman, Leonardo Martínez, Grant Theron, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1228-1228
Open Access | Times Cited: 39
Key advances in vaccine development for tuberculosis—success and challenges
Rocky Lai, Abiola F. Ogunsola, Tasfia Rakib, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Engineering Saccharomyces cerevisiae for medical applications
Carla Maneira, Alexandre Chamas, Gerald Lackner
Microbial Cell Factories (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α
Erik Van Dis, Douglas Fox, Huntly M. Morrison, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 7, pp. e1010721-e1010721
Open Access | Times Cited: 30
CD4+ T cells re-wire granuloma cellularity and regulatory networks to promote immunomodulation following Mtb reinfection
Joshua D. Bromley, Sharie Keanne C. Ganchua, Sarah K. Nyquist, et al.
Immunity (2024) Vol. 57, Iss. 10, pp. 2380-2398.e6
Open Access | Times Cited: 6
BCG vaccination strategies against tuberculosis: updates and perspectives
Mengjin Qu, Xiangmei Zhou, Hao Li
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 12, pp. 5284-5295
Open Access | Times Cited: 37
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design
Kia C. Ferrell, Matt D. Johansen, James A. Triccas, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 24
Total Synthesis of Brevianamide S
Adam R. Lockyer, Helen E. Jones, Nicholas J. Green, et al.
Organic Letters (2025)
Open Access
DNA Subunit Vaccine and Recombinant BCG Based on Mycobacterial Lipoprotein LprO Enhance Anti-Tuberculosis Protection in the Lungs of Mice
Weili Huang, Shuqin Xu, Li‐Fang Shen, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 400-400
Open Access
Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination
Sherry L. Kurtz, Lara Mittereder, Chelsea C. Lehman, et al.
Infection and Immunity (2023) Vol. 91, Iss. 7
Open Access | Times Cited: 10
Vaccination in post-tuberculosis lung disease management: A review of the evidence
Mohammad Javad Nasiri, Denise Rossato Silva, Foad Rommasi, et al.
Pulmonology (2023)
Open Access | Times Cited: 10
Mycobacterium bovis and its impact on human and animal tuberculosis
Jason Sawyer, Shelley Rhodes, Gareth J. Jones, et al.
Journal of Medical Microbiology (2023) Vol. 72, Iss. 11
Closed Access | Times Cited: 10
Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice
Sherry L. Kurtz, Richard E. Baker, Frederick J. Boehm, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1012069-e1012069
Open Access | Times Cited: 3
Live Attenuated Vaccines against Tuberculosis: Targeting the Disruption of Genes Encoding the Secretory Proteins of Mycobacteria
Raja Veerapandian, Shrikanth S. Gadad, Chinnaswamy Jagannath, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 530-530
Open Access | Times Cited: 3
Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2
Renata Fioravanti Tarabini, Maurício Rigo, André Faustino Fonseca, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 15
Immunogenicity of full-length and multi-epitope mRNA vaccines for M. Tuberculosis as demonstrated by the intensity of T-cell response: a comparative study in mice
OO Vasileva, VP Tereschenko, BN Krapivin, et al.
Bulletin of Russian State Medical University (2023), Iss. 2023(3)
Open Access | Times Cited: 9
Intranasal bovine β-defensin-5 enhances antituberculosis immunity in a mouse model by a novel protein-based respiratory mucosal vaccine
Zhengmin Liang, Hao Li, Mengjin Qu, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 949-962
Open Access | Times Cited: 10
BCG revaccination in adults enhances pro-inflammatory markers of trained immunity along with anti-inflammatory pathways
Asma Ahmed, Himanshu Tripathi, Krista E. van Meijgaarden, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107889-107889
Open Access | Times Cited: 6
After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
Mario Alberto Flores‐Valdez
Vaccines (2021) Vol. 10, Iss. 1, pp. 57-57
Open Access | Times Cited: 14
Selenium nanoparticles enhance mucosal immunity against Mycobacterium bovis infection
Xin Ge, Zhengmin Liang, Kui Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112384-112384
Closed Access | Times Cited: 1
A mucosal vaccine formulation against tuberculosis by exploiting the adjuvant activity of S100A4—A damage-associated molecular pattern molecule
Olifan Zewdie Abil, Shuwei Liu, Yu‐Wen Yeh, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126151-126151
Closed Access | Times Cited: 1
Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin
Limei Wang, Jian Kang, Hong Jiang
Vaccines (2024) Vol. 12, Iss. 9, pp. 1022-1022
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top